Management of Antithrombin Deficiency in Pregnancy

Hart, Christina and Rott, Hannelore and Heimerl, Susanne and Linnemann, Birgit (2022) Management of Antithrombin Deficiency in Pregnancy. HAMOSTASEOLOGIE, 42 (05). pp. 320-329. ISSN 0720-9355, 2567-5761

Full text not available from this repository. (Request a copy)

Abstract

Antithrombin (AT) deficiency is a high-risk thrombophilia and a rare condition. The risk of venous thromboembolism (VTE) is increased in AT-deficient women during pregnancy and the postpartum period and is especially high in women with a prior history of VTE. A thorough assessment of VTE risk is recommended in pregnant AT-deficient women, comprising the degree and type of AT deficiency, genetic mutations, personal and family history, and additional preexisting or pregnancy-specific risk factors. Due to a lack of adequate study data, there is limited guidance on the management of AT deficiency in pregnancy, including the need for prophylactic anticoagulation, the appropriate dose of low-molecular-weight heparin (LMWH), and the role of AT substitution. LMWH is the medication of choice for the pharmacological prophylaxis and treatment of VTE in pregnancy. Patients with a history of VTE should receive full-dose LMWH during pregnancy and the postpartum period. AT concentrates are a treatment option when anticoagulation is withheld in potentially high-risk events such as childbirth, bleeding, or surgery and in cases of acute VTE despite the use of therapeutic dose anticoagulation. Women with AT deficiency should be counseled at specialized centers for coagulation disorders or vascular medicine, and close cooperation between obstetricians and anesthesiologists is warranted before delivery and during the peripartum period.

Item Type: Article
Uncontrolled Keywords: VENOUS THROMBOEMBOLISM; PROTEIN-C; POSTPARTUM PERIOD; SINUS THROMBOSIS; POSITION PAPER; WOMENS HEALTH; WORKING GROUP; RISK; HEREDITARY; THROMBOPHILIA; antithrombin deficiency; heparin; anti-Xa monitoring; antithrombin concentrate; pregnancy
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin
Depositing User: Petra Gürster
Date Deposited: 01 Sep 2023 07:51
Last Modified: 01 Sep 2023 07:51
URI: https://pred.uni-regensburg.de/id/eprint/56823

Actions (login required)

View Item View Item